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Exploring the FMN binding site in the mitochondrial outer
membrane protein mitoNEET
Homyra Tasnim, Aaron P. Landry, Chelsey R. Fontenot, Huangen Ding*
Department of Biological Sciences, Louisiana State University, Baton Rouge, LA 70803, USA

Abstract
Author Manuscript
Author Manuscript

MitoNEET is a mitochondrial outer membrane protein that hosts a redox active [2Fe-2S] cluster in
the C-terminal cytosolic domain. Increasing evidence has shown that mitoNEET has an essential
role in regulating energy metabolism in human cells. Previously, we reported that the [2Fe-2S]
clusters in mitoNEET can be reduced by the reduced flavin mononucleotide (FMNH2) and
oxidized by oxygen or ubiquinone-2, suggesting that mitoNEET may act as a novel redox enzyme
catalyzing electron transfer from FMNH2 to oxygen or ubiquinone. Here, we explore the FMN
binding site in mitoNEET by using FMN analogs and find that lumiflavin, like FMN, at nanomolar
concentrations can mediate the redox transition of the mitoNEET [2Fe-2S] clusters in the presence
of flavin reductase and NADH (100 μM) under aerobic conditions. The electron paramagnetic
resonance (EPR) measurements show that both FMN and lumiflavin can dramatically change the
EPR spectrum of the reduced mitoNEET [2Fe-2S] clusters and form a covalently bound complex
with mitoNEET under blue light exposure, suggesting that FMN/lumiflavin has specific
interactions with the [2Fe-2S] clusters in mitoNEET. In contrast, lumichrome, another FMN
analog, fails to mediate the redox transition of the mitoNEET [2Fe-2S] clusters and has no effect
on the EPR spectrum of the reduced mitoNEET [2Fe-2S] clusters under blue light exposure.
Instead, lumichrome can effectively inhibit the FMNH2-mediated reduction of the mitoNEET
[2Fe-2S] clusters, indicating that lumichrome may act as a potential inhibitor to block the electron
transfer activity of mitoNEET.
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Introduction
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The mitochondrial outer membrane protein mitoNEET was initially identified as a binding
target of the type II diabetes drug pioglitazone [1]. Since, it has been demonstrated that
mitoNEET has an essential role in regulating energy metabolism, iron homeostasis, and
production of reactive oxygen species in mitochondria [2, 3]. For example, in breast cancer
cells, mitoNEET is highly expressed, and deletion of mitoNEET decreases proliferation of
the cells [4]. In primary cultured spinal neurons, knockdown of mitoNEET leads to
apoptosis [5]. In mice, mitoNEET is proposed to act as a mediator of Ca2+-facilitated
mitochondrial dysfunction [6] and to regulate the function of the mitochondrial outer
membrane protein voltage-dependent anion channel 1 (VDAC1) [7]. Mice with deletion of
mitoNEET has signs of striatal mitochondrial dysfunction and a Parkinson’s disease
phenotype [8]. Because of its role in broad physiological functions, mitoNEET has become a
novel target for treating diseases of mitochondrial dysfunction [9–12].

Author Manuscript

Human mitoNEET is a homodimer with each monomer hosting a [2Fe-2S] cluster in its Cterminal cytosolic region [13–15]. The N-terminus of mitoNEET contains a transmembrane
alpha-helix domain that anchors mitoNEET to the mitochondrial outer membrane [1]. The
specific function of the [2Fe-2S] clusters in mitoNEET, however, still remains largely
elusive. Because mitochondria are the primary sites for iron-sulfur cluster biogenesis [16], it
has been proposed that mitoNEET may act as a carrier that transfers iron-sulfur clusters
assembled in mitochondria to target proteins in cytosol or nucleus [17–21]. However, the
observed cluster transfer occurs only when the mitoNEET [2Fe-2S] clusters are in an
oxidized state [17, 19]. Since the mitoNEET [2Fe-2S] clusters are in a reduced state in cells
under normal physiological conditions [22, 23], mitoNEET may help repair the damaged
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iron-sulfur clusters in proteins when cells are under oxidative stress conditions [17].
Alternatively, mitoNEET may contribute to the anti-oxidative stress activity [3, 24], as overexpression of mitoNEET prevents the oxidative damage in A375 melanoma cells [25] and in
perivascular adipose tissue [26]. Regardless, the redox state of the [2Fe-2S] clusters has a
crucial role for the proposed physiological functions of mitoNEET. The redox midpoint
potential (Em7) of the mitoNEET [2Fe-2S] clusters has been determined to be about 0 mV at
pH 7.0 [27]. However, the physiological components responsible for reducing or oxidizing
the mitoNEET [2Fe-2S] clusters were not fully understood. In the previous studies, we
found that the mitoNEET [2Fe-2S] clusters can be rapidly reduced by FMNH2 (but not
NADH or NADPH) and oxidized by oxygen or ubiquinone [22, 28]. Because FMN can be
reduced by flavin reductase using NADH as electron donor [29], we further proposed that
mitoNEET may act as a redox enzyme catalyzing the electron transfer from NADH in
cytosol to oxygen or ubiquinone in the mitochondrial outer membrane [30]. Since oxidation
of NADH in cytosol is linked to the glycolysis activity [31, 32], mitoNEET may indirectly
regulate glycolysis by promoting oxidation of cytosolic NADH [22,30].

Author Manuscript

The molecular docking models revealed that mitoNEET has a specific FMN binding site in
the vicinity of the [2Fe-2S] cluster in each mitoNEET monomer [28]. The shortest distance
between the [2Fe-2S] cluster and the bound FMN in mitoNEET is about 10 Å, which could
facilitate rapid electron transfer from FMNH2 to the [2Fe-2S] cluster within mitoNEET. To
further explore the FMN binding site in mitoNEET, here we have utilized two FMN analogs:
lumiflavin and lumichrome. Lumiflavin and lumichrome are the photolysis products of
FMN, and retain an alloxazine chromophore of FMN [33]. Our results show that lumiflavin,
like FMN, can also mediate the reduction of the mitoNEET [2Fe-2S] clusters in the presence
of flavin reductase and NADH under aerobic conditions. Furthermore, incubation with FMN
or lumiflavin can dramatically change the electron paramagnetic resonance (EPR) spectrum
of the reduced mitoNEET [2Fe-2S] cluster and form a covalently bound complex with
mitoNEET under blue light exposure. In contrast, lumichrome fails to mediate the reduction
of the mitoNEET [2Fe-2S] clusters in the presence of flavin reductase and NADH or form a
covalently bound complex with mitoNEET under blue light exposure. Instead, lumichrome
can effectively inhibit the FMNH2-mediated reduction of the mitoNEET [2Fe-2S] clusters,
suggesting that lumichrome may compete with FMN for the FMN binding site in mitoNEET
and inhibit the electron transfer activity of mitoNEET.

Materials and methods
Protein preparation—

Author Manuscript

Human mitochondrial outer membrane protein mitoNEET33–108 (containing residues 33–
108) encoded by CISD1 gene was prepared as described previously [34]. Human CISD2
gene encoding human Miner157–135 (or NAF-157–135) (containing residues 57–135), CISD3
gene encoding Miner242–134 (or MiNT42–134) (containing residues 42–134), and FDX2 gene
encoding ferredoxin 261–186 (containing residues 61–186) were also synthesized (GenScript
co.) and cloned into an expression plasmid pET28b+. Recombinant human proteins were
purified as described for mitoNEET [34]. The E. coli flavin reductase (Fre) was prepared
using an E. coli strain hosting an expression plasmid encoding Fre from the ASKA library
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[35]. The purity of purified proteins was greater than 95% as judged by electrophoresis
analysis on a 15% polyacrylamide gel containing SDS followed by staining with Coomassie
Blue. Purified proteins were dissolved in buffer containing NaCl (500 mM) and Tris (20
mM, pH 8.0) for the experiments. To estimate concentration of purified proteins, the
extinction coefficients of 8.6, 7.5, 20.3, 7.8, 26.4 mM−1 cm−1 at 280 nm were used for
mitoNEET, Miner1, Miner2, ferredoxin-2, and Fre, respectively.
Reduction and oxidation of the mitoNEET [2Fe-2S] clusters—

Author Manuscript

The redox state of the mitoNEET [2Fe-2S] clusters was monitored using a Beckman DU640
UV-visible absorption spectrometer equipped with a temperature controller. The oxidized
mitoNEET [2Fe-2S] clusters have major absorption peaks at 458 nm and 540 nm. When the
oxidized mitoNEET [2Fe-2S] clusters are reduced, the absorption peak at 458 nm is shifted
to a much small absorption peak at 420 nm, while the absorption peak at 540 nm is not
significantly changed [28]. Thus, we used the amplitude of the absorption peak at 458 nm to
monitor the redox state of the mitoNEET [2Fe-2S] clusters in the reaction solution.
Blue light exposure—
An LED blue light source (Submersible LED light blue) was purchased from
petSolutions.com. Samples in glass vials were exposed to blue light at room temperature.
The distance between the sample and the blue light source was about 5 cm to minimize
heating from the light source. A Digital Lux Meter (LX1330B, Dr. Meter) was used to
measure the intensity of the blue light exposure.
EPR measurements—

Author Manuscript

The X-band Electron Paramagnetic Resonance (EPR) spectra were recorded using a Bruker
model ESR-300 spectrometer equipped with an Oxford Instruments 910 continuous flow
cryostat. Routine EPR conditions were: microwave frequency, 9.47 GHz; microwave power,
1.0 mW; modulation frequency, 100 kHz; modulation amplitude, 1.2 mT; temperature, 20 K;
receiver gain, 2×105.
Fluorescence measurements—
A spectrofluorometer (FP-6300, JASCO Co., Japan) was used for the fluorescence spectrum
measurements of FMN covalently bound in mitoNEET. The emission spectra of FMN were
taken at room temperature using an excitation wavelength of 450 nm. The amount of FMN
in the samples was quantified as described in [36].
Chemicals—

Author Manuscript

NADH, isopropyl-β-D-1-thiogalactopyranoside, kanamycin, and ampicillin were purchased
from Research Product International co. FMN (flavin mononucleotide), lumiflavin,
lumichrome, and other chemicals were purchased from Sigma co. The concentrations of
NADH and FMN were determined using extinction coefficients of 6.2 mM−1cm−1 at 340 nm
and 12.5 mM−1cm−1 at 445 nm, respectively [37].
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Results
1. Kinetics of the FMN-mediated reduction of the mitoNEET [2Fe-2S] clusters under
aerobic conditions

Author Manuscript

Previous studies have shown that the mitoNEET [2Fe-2S] clusters can be reduced by
FMNH2 under aerobic conditions [22, 28, 30]. Since the cytosolic concentration of FMN in
typical mammalian cells is in the nanomolar range [37], we decided to re-evaluate the
reduction kinetics of the mitoNEET [2Fe-2S] clusters at different concentrations of FMN in
the presence of NADH and flavin reductase under aerobic conditions. In the experiments,
purified human mitoNEET (containing 10 μM [2Fe-2S] clusters) was pre-incubated with
NADH (100 μM) and FMN in buffer containing NaCl (500 mM) and Tris (20 mM, pH 8.0).
The reduction of the mitoNEET [2Fe-2S] clusters was initiated by adding a catalytic amount
of flavin reductase (Fre) (at a final concentration of 0.25 μM) and monitored by
continuously taking the UV-visible absorption spectra of the mitoNEET [2Fe-2S] clusters.

Author Manuscript

Figure 1A shows that the oxidized mitoNEET [2Fe-2S] clusters had a major absorption peak
at 458 nm [38]. Upon addition of flavin reductase, the absorption peak at 458 nm of the
mitoNEET [2Fe-2S] cluster was quickly diminished and shifted to a much small absorption
peak at 420 nm of the reduced mitoNEET [2Fe-2S] clusters. Under the experimental
conditions, 50 nM of FMN was sufficient to reduce 10 μM of the mitoNEET [2Fe-2S]
clusters within 3 min (Figure 1B). As the ratio of FMN to the mitoNEET [2Fe-2S] clusters
in the reaction solution was about 1:200, the results suggest that FMN is highly efficient in
mediating the reduction of the mitoNEET [2Fe-2S] clusters. Importantly, once the NADH in
the reaction solution was fully oxidized (disappearance of the absorption peak at 340 nm),
the reduced mitoNEET [2Fe-2S] clusters were re-oxidized (re-appearance of the absorption
peak at 458 nm) by oxygen in the solution (Figure 1A), indicating that the FMNH2-mediated
reduction of the mitoNEET [2Fe-2S] clusters is reversible as described previously [22, 28,
30].

Author Manuscript

To further explore the kinetics of the redox transition of the mitoNEET [2Fe-2S] clusters, we
carried out the same experiments using different concentrations of FMN. Figure 1B shows
the redox transition of the mitoNEET [2Fe-2S] clusters at different concentrations of FMN
(0 to 250 nM) in the presence of NADH (100 μM) and flavin reductase under aerobic
conditions. Without addition of FMN, there was very little reduction of the mitoNEET
[2Fe-2S] clusters. When the concentration of FMN increased from 0 to 250 nM, the
reduction rate of the mitoNEET [2Fe-2S] clusters quickly increased. At 250 nM of FMN,
the mitoNEET [2Fe-2S] clusters were reduced in less than 1 minute and fully re-oxidized in
4 min (Figure 1B). Thus, FMN not only mediates the reduction of the mitoNEET [2Fe-2S]
clusters, but also promotes re-oxidization of the reduced mitoNEET [2Fe-2S] clusters under
aerobic conditions.
2. The FMN analog lumiflavin has a similar activity as FMN in mediating redox transition
of the mitoNEET [2Fe-2S] clusters under aerobic conditions
Previous molecular docking models indicated that human mitoNEET has a distinct FMN
binding site in the vicinity of the [2Fe-2S] cluster in each monomeric mitoNEET [28]. To
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further explore the FMN binding site in mitoNEET, we have used two FMN analogs:
lumiflavin and lumichrome (Figure 2A). Both lumiflavin and lumichrome are the photolysis
products of FMN and retain the alloxazine chromophore of FMN [33]. In the experiments,
purified human mitoNEET (containing 10 μM [2Fe-2S] clusters) was pre-incubated with
NADH and one of the FMN analogs. The reduction of the mitoNEET [2Fe-2S] clusters was
initiated by adding a catalytic amount of flavin reductase and monitored by taking UVVisible absorption spectra of the mitoNEET [2Fe-2S] clusters.

Author Manuscript

Figure 2C shows that lumiflavin had essentially the same activity as FMN (Figure 2B) in
mediating the reduction and oxidation of the mitoNEET [2Fe-2S] clusters under aerobic
conditions. In contrast, lumichrome had no such an activity under the experimental
conditions (Figure 2D). We also used the electron paramagnetic resonance (EPR)
spectroscopy to verify the redox state of the mitoNEET [2Fe-2S] clusters after incubation.
While the oxidized mitoNEET [2Fe-2S] clusters are diamagnetic and EPR silent, the
reduced mitoNEET [2Fe-2S] clusters are paramagnetic and have a distinct EPR signal at gav
= 1.94 [28, 39]. The EPR measurements confirmed that the mitoNEET [2Fe-2S] clusters
were reduced after incubation with FMN or lumiflavin in the presence of NADH and flavin
reductase under aerobic conditions, but not with lumichrome (data not shown). Thus,
lumiflavin, like FMN, can efficiently mediate the reduction and oxidation of the mitoNEET
[2Fe-2S] clusters in the presence of NADH and flavin reductase under aerobic conditions.
3.

FMN forms a covalently bound complex with mitoNEET under blue light exposure

Author Manuscript
Author Manuscript

Because flavin can be excited by blue light (at around 450 nm) [40], it has been reported that
blue light excitation may result in formation of a covalently bound protein-FMN complex in
FMN binding proteins [41, 42]. If mitoNEET binds FMN as predicted in the molecule
docking models [28], we would expect that blue light excitation may also promote formation
of a covalently bound complex between FMN and mitoNEET. In the experiments,
mitoNEET was incubated with five-fold excess of FMN under blue light exposure (50,000
Lux) at room temperature for 10 min, followed by adding freshly prepared sodium dithionite
to reduce the mitoNEET [2Fe-2S] clusters. The EPR measurements showed that the reduced
mitoNEET [2Fe-2S] clusters had a new EPR signal at g = 1.85 after incubation with FMN
(Figure 3, spectrum 2). A similar but small EPR signal at g = 1.85 was previously observed
when the mitoNEET [2Fe-2S] clusters were incubated with FMN under room light for 30
min [28]. We postulated that blue light exposure may have generated more light-excited
FMN for the interaction with the mitoNEET [2Fe-2S] clusters than room light exposure.
Importantly, same EPR signal at g =1.85 was also observed when mitoNEET was incubated
with five-fold excess of lumiflavin under blue light exposure (Figure 3, spectrum 3), but not
with lumichrome (Figure 3, spectrum 4). While the nature of the unusual EPR signal at g =
1.85 of the reduced mitoNEET [2Fe-2S] clusters is not fully understood, the results strongly
suggest that FMN and lumiflavin, but not lumichrome, have distinct interactions with the
mitoNEET [2Fe-2S] clusters.
As blue light has been shown to induce dimerization in the FMN binding protein
aureochrome-1 [43], we asked whether FMN could also promote dimerization of mitoNEET
under blue light exposure. After mitoNEET was incubated with different concentrations of
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FMN under blue light exposure for 10 min, the samples were subjected to the SDS-PAGE
analyses. Figure 4A shows that mitoNEET indeed became a covalently bound homodimer
after incubation with FMN under blue light exposure. The observed mitoNEET dimer (D)
could not be separated to monomers by incubation with 10 mM dithiothreitol, indicating that
the mitoNEET dimer was not formed via disulfide. Thus, mitoNEET most likely became a
covalently bound homodimer after incubation with FMN under blue light exposure.

Author Manuscript

After incubation with FMN under blue light exposure, mitoNEET was re-purified from the
incubation solutions by passing the sample through a High-Trap Desalting column to
remove unbound FMN. Re-purified mitoNEET samples were then subjected to the UVvisible absorption measurements. Figure 4B shows that incubation of mitoNEET with FMN
under blue light exposure resulted in a major absorption peak at 250 nm (spectrum 1).
Without FMN or blue light exposure, no absorption change of mitoNEET was observed
(spectra 2, 3, 4). The re-purified mitoNEET was further subjected to analysis of FMN in the
protein using the fluorescence spectrometry as described in [36]. Upon excitation at 450 nm,
FMN has a fluorescence peak at around 520 nm [36]. Figure 4C shows that while the repurified mitoNEET after incubation without FMN under blue light exposure did not have
any fluorescence peaks at 520 nm (Figure 4, spectrum 3), the re-purified mitoNEET after
incubation with FMN under blue light exposure had a major peak of fluorescence at 520 nm
(Figure 4C, spectrum 2). Addition of 0.2% SDS to denature mitoNEET further enhanced the
fluorescence intensity of FMN in the mitoNEET sample incubated with FMN under blue
light exposure (Figure 4C, spectrum 1). Using the FMN solution as a standard, we estimated
that at least 0.2 moles of FMN were present per each mole of the mitoNEET dimer after
incubation with five-fold excess of FMN under blue light exposure for 10 min. Similar
results were also observed when mitoNEET was incubated with lumiflavin, but not with
lumichrome (data not shown). Thus, FMN can not only change the EPR spectrum of the
reduced mitoNEET [2Fe-2S] clusters (Figure 3), but also form a covalently bound complex
with mitoNEET (Figure 4) under blue light exposure.

Author Manuscript

4.

The interaction between FMN and the mitoNEET [2Fe-2S] clusters is unique
The observed EPR signal at g = 1.85 of the reduced mitoNEET [2Fe-2S] clusters after
incubation with FMN under blue light exposure was not previously reported in any ironsulfur proteins. It would be of interest to examine whether FMN could also change the EPR
spectrum of the [2Fe-2S] clusters in other proteins under blue light exposure.

Author Manuscript

To test this idea, we prepared three human mitochondrial proteins that contain [2Fe-2S]
clusters: the mitoNEET-related protein 1 (Miner1 or NAF-1) [44, 45], the mitoNEET-related
protein 2 (Miner2 or MiNT) [46, 47], and the mitochondrial ferredoxin 2 [48]. Miner1 is a
homolog of mitoNEET with 54% identity and 69% similarity [44], and localizes in the
mitochondrial outer membrane and endoplasmic reticulum membrane [45]. Miner2 is a
mitochondrial matrix protein with no sequence similarities to mitoNEET or Miner1, but has
the same ligands (three cysteine and one histidine residues) as mitoNEET for hosting the
[2Fe-2S] cluster [46, 47]. Mitochondrial ferredoxin 2 is a key member of the iron-sulfur
cluster biogenesis machinery in mitochondria [48], and has no sequence similarities to
mitoNEET or Miner2. Three human mitochondrial proteins (Miner1, Miner2 and ferredoxin
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2) were expressed in E. coli cells and purified as mitoNEET. Each of purified proteins
contained one or two [2Fe-2S] clusters and had their distinct EPR spectra (Figure 5A). Each
purified protein was then incubated with FMN under blue light exposure for 10 min,
followed by reduction with freshly prepared sodium dithionite. The samples were transferred
to EPR tubes, frozen immediately in liquid nitrogen until the EPR measurements. Figure 5B
shows that after incubation with FMN under blue light exposure, the reduced Miner1
[2Fe-2S] clusters had the same EPR signal at g =1.85 as the reduced mitoNEET [2Fe-2S]
clusters (spectra 5 and 6), indicating that the mitoNEET homolog Miner1 has the same
interactions with FMN as mitoNEET. In contrast, incubation with FMN resulted in no EPR
signal of the reduced Miner2 [2Fe-2S] clusters (Figure 5, spectrum 7) or the reduced
ferredoxin2 [2Fe-2S] clusters (Figure 5, spectrum 8) under blue light exposure, likely due to
the disruption of the [2Fe-2S] clusters in the proteins by excited FMN or other reactive free
radicals under blue light exposure. Thus, not all [2Fe-2S] cluster proteins will have the
unique EPR signal at g = 1.85 after incubation with FMN under blue light exposure, and the
interaction between mitoNEET and FMN is unique.

Author Manuscript

5.

Lumichrome inhibits the FMNH2-mediated reduction of the mitoNEET [2Fe-2S] clusters
Unlike FMN or lumiflavin, lumichrome fails to mediate the reduction of the mitoNEET
[2Fe-2S] clusters in the presence of NADH and flavin reductase under aerobic conditions
(Figure 2D) and has no effect on the EPR spectrum of the reduced mitoNEET [2Fe-2S]
clusters under blue light exposure (Figure 3, spectrum 4). Since lumichrome has an
isoalloxazine group as FMN, we reasoned that lumichrome may compete with FMN for the
FMN binding site in mitoNEET and inhibit the electron transfer activity of mitoNEET.

Author Manuscript

To test the idea, mitoNEET (containing 10 μM [2Fe-2S] clusters) was pre-incubated with
FMN (50 nM) and various concentrations of lumichrome (0 to 250 nM) in the presence of
NADH (100 μM) under aerobic conditions for 10 min. The reduction of the mitoNEET
[2Fe-2S] clusters in the solutions was initiated by adding a catalytic amount of flavin
reductase (0.25 μM) as described previously. Figure 6 shows that as the concentration of
lumichrome increased in the pre-incubation solutions, the FMN-mediated reduction of the
mitoNEET [2Fe-2S] clusters gradually decreased. Upon addition of 250 nM of lumichrome,
about 50% of the FMNH2-mediated reduction of the mitoNEET [2Fe-2S] clusters was
inhibited under the experimental conditions (Figure 6D), suggesting that lumichrome is a
potent inhibitor to block the electron transfer activity of mitoNEET.

Discussion
Author Manuscript

MitoNEET is the first iron-sulfur protein identified in the mitochondrial outer membrane
[1]. The unique location of mitoNEET and its redox active [2Fe-2S] clusters have attracted
great attentions in the past decade. In the previous studies, we reported that the mitoNEET
[2Fe-2S] clusters can be readily reduced by FMNH2 and oxidized by oxygen or ubiquinone
[22, 28, 30], and suggested that mitoNEET may act as a novel redox enzyme to catalyze
electron transfer from FMNH2 to oxygen or ubiquinone. To further explore the FMN
binding site of mitoNEET, here we have utilized two FMN analogs, and found that
lumiflavin can substitute for FMN in mediating the reduction of the mitoNEET [2Fe-2S]
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clusters in the presence of NADH and flavin reductase under aerobic conditions. Under blue
light exposure, both FMN and lumiflavin can dramatically change the EPR spectrum of the
reduced mitoNEET [2Fe-2S] clusters with an unusual EPR signal at g = 1.85 and form a
covalently bound complex with mitoNEET. In contrast, lumichrome, which lacks a methyl
group on isoalloxazine (Figure 2A), fails to mediate the reduction of the mitoNEET
[2Fe-2S] clusters or change the EPR spectrum of the reduced mitoNEET [2Fe-2S] clusters.
Instead, lumichrome can effectively inhibit the electron transfer activity of mitoNEET, likely
by competing with FMN for the FMN binding site in mitoNEET.

Author Manuscript
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In the crystal structure, mitoNEET exists as a homodimer with two mitoNEET monomers
associated via a “beta cap” structure, bringing the two [2Fe-2S] clusters close to each other
with a closest distance of about 13Å [13–15]. Molecular docking models further revealed a
putative FMN binding site in mitoNEET which localizes at the region between the
transmembrane α-helix domain and the [2Fe-2S] cluster binding domain [28]. The short
distance between FMN and the [2Fe-2S] clusters in mitoNEET could facilitate the rapid
electron transfer from FMNH2 to the [2Fe-2S] cluster [28]. Lumiflavin has the same
isoalloxazine group as FMN (Figure 2A). Like FMN, lumiflavin has almost the same
activity as FMN in mediating the reduction of the mitoNEET [2Fe-2S] clusters in the
presence of NADH and flavin reductase under aerobic conditions (Figure 2C), changing the
EPR spectrum of the reduced mitoNEET [2Fe-2S] clusters under blue light exposure (Figure
3, spectrum 3), and forming a covalently bound complex with mitoNEET (data not shown),
suggesting that both FMN and lumiflavin have specific interactions with mitoNEET. On the
other hand, lumichrome fails to mediate the reduction of the mitoNEET [2Fe-2S] clusters
and has no effect on the EPR spectrum of the reduced mitoNEET [2Fe-2S] cluster after blue
light exposure (Figures 2 and 3). Instead, lumichrome effectively inhibits the FMNH2mediated reduction of the mitoNEET [2Fe-2S] clusters (Figure 6). The subtle difference
between lumiflavin and lumichrome (a methyl group on isoalloxazine, Figure 2A) appears to
have a critical role in determining their interactions with the mitoNEET [2Fe-2S] clusters.

Author Manuscript

In addition to mitoNEET, there are two mitoNEET-related proteins, the mitoNEET-related
protein 1 (Miner1) or Nutrient-Deprivation Autophagy Factor-1(NAF-1) [44, 45] and the
mitoNEET-related protein 2 (Miner2 or MiNT) [46, 47, 49] in human mitochondria. Like
mitoNEET [13–15], both Miner1 and Miner2 host a [2Fe-2S] cluster via an unusual legend
arrangement of three cysteine and one histidine residues. However, mitoNEET and Miner1
are homologous with 54% identity and 69% similarity [44]. Recent studies further indicated
that mitoNEET and Miner1 may share similar physiological functions [4, 50], have specific
interactions with the type II diabetes drug pioglitazone and other thiazolidinediones [51],
and may even form a mitoNEET-Miner1 dimer [52]. Mutations of Miner1 have been
attributed to Wolfram Syndrome 2, a metabolic disease associated with diabetes, blindness,
deafness, and a shortened lifespan [50, 53]. In consistent with these observations, here we
have found that mitoNEET and Miner1 have similar interactions with FMN (Figure 5). On
the other hand, Miner2, which does not have the sequence similarities to mitoNEET or
Miner1 [47], does not have specific interactions with FMN under blue light exposure (Figure
5, spectrum 7). Likewise, human ferredoxin-2, which does not have any sequence
similarities to mitoNEET or Miner1[48], does not have interactions with FMN under blue
light exposure (Figure 5, spectrum 8). Thus, mitoNEET and its homolog Miner1 may have a
Free Radic Biol Med. Author manuscript; available in PMC 2021 August 20.

Tasnim et al.

Page 10

Author Manuscript

specific binding site for FMN to facilitate rapid reduction of the mitoNEET [2Fe-2S]
clusters by FMNH2.
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Together with cytosolic flavin reductase which catalyzes reduction of FMN and oxidization
of NADH [29], mitoNEET may effectively promote oxidation of NADH in cytosol with
reduction of oxygen or ubiquinone (Figure 7) [30]. Because oxidation of NADH in cytosol is
required for glycolysis activity [31, 32], mitoNEET on the mitochondrial outer membrane
may indirectly regulate glycolysis via promoting oxidation of cytosolic NADH [22, 30].
This notion is consistent with the findings that deletion of mitoNEET decreases the oxidative
phosphorylation activity [54], and overexpression of mitoNEET increases ATP synthesis in
cells [55]. It may be envisioned that inhibition of the electron transfer activity of mitoNEET
will decrease oxidation of NADH in cytosol (and therefore glycolysis) and overall energy
metabolism in cells. In previous studies, we reported that the type II diabetes drug
pioglitazone can inhibit the electron transfer activity of mitoNEET [22, 28]. The docking
modelling indicated that the pioglitazone binding site in mitoNEET [11] has a partial
overlap with the FMN binding site [22], indicating that binding of pioglitazone may block
the access of FMNH2 to reduce the [2Fe-2S] clusters in mitoNEET. In this context, we
propose that the FMN analog lumichrome, which has the same isoalloxazine group as FMN,
may compete with FMN for the FMN binding site in mitoNEET, inhibit the electron transfer
activity of mitoNEET (Figure 7), and modulate overall energy metabolism in cells.
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Highlights
•

MitoNEET is a mitochondrial outer membrane protein with a [2Fe-2S] cluster

•

MitoNEET catalyzes the electron transfer from FMNH2 to O2 or ubiquinone.

•

Lumiflavin has the same activity as FMN in mediating electron transfer in
mitoNEET.

•

Lumichrome acts as an inhibitor to block the FMNH2 binding in mitoNEET.
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Figure 1. Electron transfer activity of mitoNEET at different concentrations of FMN under
aerobic conditions.

Author Manuscript

A), reduction and oxidation of the mitoNEET [2Fe-2S] clusters. MitoNEET (containing 10
μM [2Fe-2S] clusters) was incubated with NADH (100 μM), and FMN (50 nM) in buffer
containing NaCl (500 mM) and Tris (20 mM, pH 8.0) under aerobic conditions. The reaction
was initiated by adding flavin reductase (Fre) (at a final concentration of 0.25 μM). The
redox state of the mitoNEET [2Fe-2S] clusters in the reaction solutions was monitored by
taking UV-Visible absorption spectra every two minutes for 20 min. B), kinetics of reduction
and oxidation of the mitoNEET [2Fe-2S] clusters. MitoNEET (containing 10 μM [2Fe-2S]
clusters) was incubated with NADH (100 μM) and FMN (0 to 250 nM as indicated) in buffer
containing NaCl (500 mM) and Tris (20 mM, pH 8.0) under aerobic conditions. The reaction
was initiated by adding flavin reductase (Fre) (at a final concentration of 0.25 μM). The
relative amounts of the oxidized mitoNEET [2Fe-2S] clusters were monitored at the
absorption peak of 458 nm and plotted as a function of time after addition of flavin
reductase. The data were representatives from three independent experiments.
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Figure 2. Lumiflavin can substitute FMN in mediating the redox transition of the mitoNEET
[2Fe-2S] clusters under aerobic conditions.
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A), structure of FMN, lumiflavin, and lumichrome. B), reduction and oxidation of the
mitoNEET [2Fe-2S] clusters mediated by FMN, lumiflavin, and lumichrome. MitoNEET
(containing 10 μM [2Fe-2S] clusters) was incubated with NADH (100 μM), and FMN (250
nM) in buffer containing NaCl (50 mM) and Tris (20 mM, pH 8.0) under aerobic conditions.
The reaction was initiated by adding flavin reductase (Fre) (at a final concentration of 0.25
μM). C), same as B), except FMN was replaced with lumiflavin (250 nM). D), same as B),
except FMN was replaced with lumichrome (250 nM). The data were representatives of
three independent experiments.
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Figure 3. Effect of FMN analogs on the EPR spectrum of the mitoNEET [2Fe-2S] clusters.
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MitoNEET (containing 10 μM [2Fe-2S] clusters) (spectrum 1) was incubated with 50 μM of
FMN (spectrum 2), 50 μM of lumiflavin (spectrum 3), or 50 μM of lumichrome (spectrum 4)
at room temperature for 10 min under blue light exposure (50,000 Lux). The samples were
then reduced with freshly prepared sodium dithionite (10 mM), transferred to EPR tubes,
and frozen immediately in liquid nitrogen until EPR measurements. The reduced mitoNEET
[2Fe-2S] clusters have an average g = 1.94. The reduced mitoNEET [2Fe-2S] clusters after
incubation with FMN or lumiflavin under blue light exposure have a new EPR signal at g =
1.85.
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Figure 4. MitoNEET forms a covalently bound complex with FMN under blue light exposure.
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A), the SDS-PAGE analysis of mitoNEET after incubation with different concentrations of
FMN under blue light exposure. MitoNEET (containing 10 μM [2Fe-2S] clusters) was
incubated with FMN (0 to 40 μM) under blue light exposure (50,000 Lux) for 10 min.
Aliquots were taken from the samples for the SDS-PAGE analysis. Lane 1, mitoNEET.
Lanes 2–8, mitoNEET incubated with 0, 1, 2, 5, 10, 20, 40 μM of FMN under blue light
exposure for 10 min, respectively. Lane 9, MitoNEET incubated with FMN (40 μM) for 10
min without blue light exposure. On right side of the gel, M, monomeric mitoNEET; D,
dimeric mitoNEET.B), UV-Visible absorption spectra of mitoNEET after incubation with
FMN with or without blue light exposure. MitoNEET (containing 10 μM [2Fe-2S] clusters)
was incubated with or without FMN (40 μM) under blue light exposure (50,000 Lux) for 10
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min. MitoNEET protein was re-purified from the incubation solutions by passing through a
Desalting Column. Re-purified mitoNEET samples were subjected to the UV-Visible
absorption measurements. C), quantification of FMN in the re-purified mitoNEET proteins.
Re-purified mitoNEET proteins (5 μM) treated with or without 0.2% SDS were subjected to
the fluorescence measurements in a spectrofluorometer (FP-6300, JASCO Co., Japan). The
emission spectra of FMN were taken upon excitation at 450 nm. Spectrum 1, re-purified
mitoNEET after incubation with FMN under blue light exposure was treated with 0.2%
SDS. Spectrum 2, re-purified mitoNEET after incubation with FMN under blue light
exposure. Spectrum 3, mitoNEET (not incubated with FMN) was treated with 0.2 % SDS.
Spectrum 4, mitoNEET (control). Based on the fluorescence intensity of FMN in the
mitoNEET incubated with FMN under blue light exposure and treated with 0.2% SDS, we
estimated that there was at least 0.2 FMN per mitoNEET monomer (n=3).
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Figure 5. Effect of FMN on other [2Fe-2S] proteins from human mitochondria.
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Three human iron-sulfur proteins (Miner1, Miner2 and ferredoxin-2) were prepared and
incubated with FMN under blue light exposure (50,000 Lux) for 10 min. A), purified
proteins (each containing 10 μM [2Fe-2S] clusters) were reduced with freshly prepared
sodium dithionite (4 mM) without incubation with FMN. Spectrum 1, mitoNEET; spectrum
2, Miner1; spectrum 3, Miner2; Spectrum 4, ferredoxin-2. B), purified protein (containing
10 μM [2Fe-2S] clusters) was incubated with FMN (50 μM) under blue light exposure for 10
min, followed by addition of sodium dithionite (4 mM). Spectrum 1, mitoNEET; spectrum 2,
Miner1; spectrum 3, Miner2; Spectrum 4, ferredoxin-2. The data are representatives of three
independent experiments.
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Figure 6. Inhibition of the electron transfer activity of mitoNEET by lumichrome.
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A), reduction and oxidation of the mitoNEET [2Fe-2S] clusters without lumichrome.
Purified mitoNEET (containing 10 μM [2Fe-2S] clusters) was incubated with NADH (100
μM), and FMN (50 nM) in buffer containing NaCl (500 mM) and Tris (20 mM, pH 8.0)
under aerobic conditions. The reaction was initiated by adding flavin reductase (Fre) (at a
final concentration of 0.25 μM). The redox state of the mitoNEET [2Fe-2S] clusters was
monitored by taking UV-Visible absorption spectra every 2 minutes after addition of flavin
reductase. B), same as in A), except 50 nM of lumichrome was included in the incubation
solution before the reaction was initiated. C), same as in A), except 100 nM of lumichrome
was included in the incubation solution before the reaction was initiated. D), same as in A,
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except 250 nM of lumichrome was included in the incubation solution before the reaction
was initiated. The data are representatives of three independent experiments.
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Figure 7. A proposed model for the electron transfer activity of mitoNEET and inhibition by
lumichrome.
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In cytosol, NADH generated by glycolysis is oxidized by flavin reductase and FMN is
reduced to FMNH2. FMNH2 interacts with mitoNEET via specific binding site and transfers
its electrons to the [2Fe-2S] clusters of mitoNEET dimer which localizes on the
mitochondrial outer membrane (MOM). MIM, mitochondrial inner membrane. The reduced
[2Fe-2S] clusters in mitoNEET dimer transfer the electrons to oxygen or ubiquinone.
Lumichrome, which has an alloxazine group as FMN, may compete with FMN for the FMN
binding site in mitoNEET and inhibit the electron transfer activity of mitoNEET.
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